Intestinal fatty acid-binding protein, a biomarker of intestinal barrier dysfunction, increases with the progression of type 2 diabetes

Lignende værker

• Intestinal mucosal barrier dysfunction participates in the progress of nonalcoholic fatty liver disease
  af: Mao, Jing-Wei, et al.
  Udgivet: (2015)
• Intestinal Fatty Acid Binding Protein, a Biomarker of Intestinal Barrier, is Associated with Severity of Psoriasis
  af: Sikora, Mariusz, et al.
  Udgivet: (2019)
• Intestinal fatty acid‐binding protein mediates atherosclerotic progress through increasing intestinal inflammation and permeability
  af: Zhang, Lulu, et al.
  Udgivet: (2020)
• Serum biomarkers of intestinal barrier dysfunction predict postoperative endoscopic recurrence in Crohn’s disease patients
  af: Luxuan Tan, et al.
  Udgivet: (2025-09-01)
• Mechanisms of intestinal barrier dysfunction in sepsis
  af: Yoseph, Benyam P., et al.
  Udgivet: (2016)